✉ info@591daili.com☎ +86-18553102138
📞 WhatsAppEnglish
圣和化工
首页 › 产品目录 › 坦西罗莫司

坦西罗莫司

CAS 162635-04-3C56H87NO16MW 1030.3

坦西罗莫司,CAS 登记号 162635-04-3,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于有机化学品。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。

规格参数

CAS号162635-04-3
分子式C56H87NO16
分子量1030.3
LogP5.6
纯度按批次COA提供(不公开发布)
包装按订单/批次确认(不公开发布)
应用领域有机化学品
类别有机化学品

用途与场景

有机化学品

包装与供货

包装规格按订单/批次确认(不公开发布)
纯度规格按批次COA提供(不公开发布)
储存条件密封、阴凉干燥处保存
供货周期现货/按订单安排

文件与支持

每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。

常见问题

在哪里能查到 坦西罗莫司 的 CAS 号?

本页已列出 坦西罗莫司 的 CAS 号:162635-04-3,可与随货 COA 核对。

可以提供哪些规格和包装?

常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。

坦西罗莫司 一般用在什么产品里?

主要涉及有机化学品。

下单流程是怎样的?

来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。

PubChem 公开数据

Description

Temsirolimus · CAS 162635-04-3 · C56H87NO16. UNII 624KN6GM2T. Solubility: 2.35e-03 g/L.

Identification

CAS Registry Number162635-04-3
PubChem CID6918289
Molecular formulaC56H87NO16
UNII (FDA)624KN6GM2T

Computed Descriptors

Molecular Weight1030.3
XLogP35.6
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count16
Rotatable Bond Count11
Exact Mass1029.60248569
Monoisotopic Mass1029.60248569
Topological Polar Surface Area242
Heavy Atom Count73
Formal Charge0

Physical & Chemical Properties

Solubility2.35e-03 g/L

Physical description & handling notes

  • Solid
  • White to off-white powder
  • White solid
  • Practically insoluble in water; soluble in alcohol
  • Solubility is independent of pH
  • Soluble in water

GHS Hazard Classification

Reported hazard statementsH360 (50.8%), H410 (95.1%)

H360 (50.8%): May damage fertility or the unborn child [Danger Reproductive toxicity]

H360FD (45.9%): May damage fertility; May damage the unborn child [Danger Reproductive toxicity]

Documented Uses

  • Preparation: J. S. Skotnicki et al., US 5362718 (1994 to Am. Home Prod.)
  • For the treatment of renal cell carcinoma (RCC). Also investigated for use/treatment in breast cancer, lymphoma (unspecified), rheumatoid arthritis, and multiple myeloma.
  • Temsirolimus is an inhibitor of cell proliferation and anticancer agent that is used as treatment of advanced renal cell cancer. Temsirolimus therapy is frequently associated with mild serum enzyme elevations, but has yet to be linked to instances of clinically apparent liver injury with jaundice.
  • Breast Feeding; Lactation; Immunosuppressive Agents
  • Antineoplastic Agents; Transplant Drugs
  • Temsirolimus is approved to treat:

Synonyms

Temsirolimus; CCI-779; 162635-04-3; Torisel; 624KN6GM2T; DTXSID2040945; DTXCID0020945; Rapamycin 42-(2,2-bis(hydroxymethyl)propionate); Rapamycin, 42-(3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate); temsirolimusum; L01XE09; Temsirolimus Injection; RefChem:56883; MFCD00934421; CHEMBL1201182; NCGC00167518-01

Frequently Asked Questions

What are the CAS number and molecular formula of Temsirolimus?

CAS 162635-04-3; molecular formula C56H87NO16; molecular weight — g/mol.

What other names is Temsirolimus known by?

Temsirolimus, CCI-779, 162635-04-3, Torisel, 624KN6GM2T, DTXSID2040945.

Is Temsirolimus classified as hazardous?

Hazard statements reported: H360, H410.

What are the key physical properties of Temsirolimus?

Solubility: 2.35e-03 g/L.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

同类推荐

获取 坦西罗莫司 报价

供应商:济南圣和化工有限公司 · 一个工作日内回复。

邮件询价 WhatsApp
鲁ICP备19031700号-1